Treatment Registry
TR-0719 ActiveRecorded September 2, 2026

Compounded semaglutide

Sold by ReflexMD · every compounded semaglutide record

The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.

What you actually pay

Per month

$297

Medication · Monthly plan$297

Added from the figures recorded below.

Price

TermPer monthCharged today
Monthly plan

Compounded $297/mo Semaglutide

source

Per month$297Charged today$297
Visit ReflexMD

We earn nothing from this link. ReflexMD has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.

History

One reading so far. A price history appears here after the next verification pass.

  • September 2, 2026Entry added to the register

Sourcing and terms

Cancellation“If you are a Non-California resident you must call us at +1(866) 849-6382 to cancel your ReflexMD Program membership. If you are a California resident you can call us at +1(866) 849-6382 or email us at help@reflexmd.com and directly request a cancellation.”

Not yet checked: pharmacy, states, prescriber, membership and consult fee.

Recorded from reflexmd.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.

Notes

  1. 1. September 2, 2026The rendered homepage's VISIBLE TEXT shows $297/mo Semaglutide and $367/mo Tirzepatide, but the DOM also contains a second, non-visible price block quoting $299/mo Semaglutide and $399/mo Tirzepatide (likely an A/B variant or stale slide) -- only the visible figures are reported here. The Terms page states the ReflexMD Program Membership Fee 'includes the cost of medication,' so this is a real program price, not a medication-excluding membership fee. A separate '3-in-1 Weight Control Pills' product at $199/mo ($7/day) is advertised alongside 'GLP-1s' as a distinct, non-GLP-1 category ('3-month plans of GLP-1s or Weight Control Pills' and a 'View GLP-1 Injections' link from the pill page) so it was excluded as out of scope. No vial/pen form or served-states list is disclosed anywhere checked.

Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.

This record

Entry
TR-0719
Readings
1

Related records

What else ReflexMD sells

All ReflexMD programs and terms

Compounded semaglutide at a similar price

The records either side of this one in the recorded spread. Not a ranking, and not a recommendation — a position among 298 records of the same molecule.

Cite this entry

Treatment Registry. (2026). ReflexMD compounded semaglutide (TR-0719). Last verified September 2, 2026. Retrieved [your access date], from https://treatmentregistry.com/registry/TR-0719

Replace the bracket with the date you read it. Ours is the date we last checked the figures, which is a different thing and is given separately.